We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+1.31%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$592M
AUM Growth
-$7.66M
Cap. Flow
-$9.36M
Cap. Flow %
-1.58%
Top 10 Hldgs %
42.35%
Holding
83
New
–
Increased
25
Reduced
31
Closed
3

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$711K
2
PAYX icon
Paychex
PAYX
+$550K
3
ABBV icon
AbbVie
ABBV
+$359K
4
DHR icon
Danaher
DHR
+$328K
5
STT icon
State Street
STT
+$309K

Top Sells

Rank Stock Value
1
NKTR icon
Nektar Therapeutics
NKTR
+$6.18M
2
KOF icon
Coca-Cola Femsa
KOF
+$4.56M
3
CTXS
Citrix Systems Inc
CTXS
+$1.35M
4
AGNC icon
AGNC Investment
AGNC
+$420K
5
TIF
Tiffany & Co.
TIF
+$302K

Sector Composition

Rank Sector Weight
1 Healthcare 37.27%
2 Technology 13.27%
3 Industrials 11.13%
4 Consumer Staples 8.62%
5 Energy 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$29.5B
$40.8M 6.9%
101,121
+1,772
+2% +$711K
TIF
2
DELISTED
Tiffany & Co.
TIF
$31.9M 5.39%
347,516
-3,380
-1% -$302K
BF.B icon
3
Brown-Forman Class B
BF.B
$12.1B
$25.6M 4.32%
799,191
-4,528
-0.6% -$137K
CGNX icon
4
Cognex
CGNX
$10.5B
$24.9M 4.2%
1,030,440
-1,200
-0.1% -$29.5K
NVO
5
Novo Nordisk
NVO
$219B
$22.1M 3.73%
807,710
-7,950
-1% -$223K
ADI icon
6
Analog Devices
ADI
$181B
$22M 3.72%
343,491
-2,650
-0.8% -$172K
JNJ icon
7
Johnson & Johnson
JNJ
$599B
$21.9M 3.7%
224,884
-1,453
-0.6% -$146K
DHR icon
8
Danaher
DHR
$142B
$21.9M 3.7%
380,701
+5,720
+2% +$328K
DXCM icon
9
DexCom
DXCM
$29.2B
$21.8M 3.68%
1,091,100
+3,000
+0.3% +$52.7K
GWW icon
10
W.W. Grainger
GWW
$64.7B
$17.9M 3.02%
75,520
-45
-0.1% -$10.9K
SLB icon
11
SLB Ltd
SLB
$69.4B
$17.5M 2.95%
202,832
+1,087
+0.5% +$98.1K
NEOG icon
12
Neogen
NEOG
$2.18B
$17.4M 2.94%
977,709
+5,530
+0.6% +$95.8K
HON icon
13
Honeywell
HON
$71.7B
$17.3M 2.91%
188,313
-668
-0.4% -$62.3K
HSIC icon
14
Henry Schein
HSIC
$9.82B
$15.4M 2.59%
275,754
-2,209
-0.8% -$122K
SYT
15
DELISTED
Syngenta Ag
SYT
$15.4M 2.59%
188,314
-3,033
-2% -$244K
RTN
16
DELISTED
Raytheon Company
RTN
$13.9M 2.34%
144,936
-56
-0% -$5.87K
AMGN icon
17
Amgen
AMGN
$197B
$13.8M 2.34%
90,217
-1,325
-1% -$212K
WSM icon
18
Williams-Sonoma
WSM
$26.3B
$12.3M 2.07%
298,440
-720
-0.2% -$28.2K
IDXX icon
19
Idexx Laboratories
IDXX
$44.5B
$11.8M 1.99%
183,965
+975
+0.5% +$67.5K
CTXS
20
DELISTED
Citrix Systems Inc
CTXS
$9.79M 1.65%
175,150
-25,377
-13% -$1.35M
ABBV icon
21
AbbVie
ABBV
$448B
$9.45M 1.6%
140,665
+5,500
+4% +$359K
TRMB icon
22
Trimble
TRMB
$12.4B
$9.13M 1.54%
389,210
-75
-0% -$1.83K
GE icon
23
GE Aerospace
GE
$354B
$8.68M 1.46%
68,127
+1,962
+3% +$254K
SSYS icon
24
Stratasys
SSYS
$701M
$8.65M 1.46%
247,569
-3,783
-2% -$159K
PODD icon
25
Insulet
PODD
$11.6B
$8.56M 1.44%
276,225
+4,350
+2% +$128K
1
2 3 4

Similar funds

IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
SGAM
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
AB
AT Bancorp Dubuque, Iowa $823M AUM 0.35% 1-Year Est. Return
NTC
NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return

Tirschwell & Loewy's Q2 2015 Portfolio in Review

As of Q2 2015, Tirschwell & Loewy held 83 positions worth $592M, down 1.3% from $600M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 3.6%. Tirschwell & Loewy opened no new positions and exited 3, leaving the 83-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 37% a quarter earlier, followed by Technology and Industrials.

  • Tirschwell & Loewy added most to Biogen in Q2 2015, an estimated $711K increase.
  • Tirschwell & Loewy's biggest Q2 2015 reduction was Nektar Therapeutics, cutting an estimated $6.18M.
  • Tirschwell & Loewy fully exited AGNC Investment in Q2 2015, selling an estimated $420K.
  • Tirschwell & Loewy's ten largest holdings make up 42% of its $592M portfolio in Q2 2015.
  • Tirschwell & Loewy opened 0 new positions and closed 3 in Q2 2015.
  • Tirschwell & Loewy's portfolio value fell 1.3% quarter-over-quarter to $592M.

Based on Tirschwell & Loewy's 13F filing for Q2 2015, filed 6 Aug 2015.